The Electronic Asthma Action Plan System for Implementation in Primary Care (EAAPS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Asthma is a common and potentially fatal chronic disease. An asthma action plan (AAP) is a written plan produced by a physician for a patient with asthma, to provide education and guidelines for self-management of worsening asthma symptoms. Studies have shown that AAPs effectively improve asthma control, but physicians fail to provide AAPs due to lack of time and adequate skills. The investigators propose to develop a computerized tool that will automatically generate an electronic version of the AAP, based on patient responses to questions about their current asthma control. The investigators hope that this system will eliminate the barriers that physicians face in delivery of an AAP and will increase the frequency with which physicians are able to deliver AAPs to patients with asthma. The objectives of the study are to determine the impact of an electronic asthma action plan system on asthma action plan delivery by primary care physicians, to determine the impact of an electronic asthma action plan system on patient hospitalisations, emergency room (ER) visits, unscheduled visits to the doctor, total visits to the doctor, days off work or school, nocturnal asthma symptoms, daytime asthma symptoms, daytime rescue puffer use, and quality of life , and to measure physicians' perceptions of and satisfaction with the system.
| Condition | Intervention | Phase |
|---|---|---|
|
Asthma |
Other: Electronic Asthma Action Plan System |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | The Electronic Asthma Action Plan System for Implementation in Primary Care |
- The primary outcome will be the percentage of eligible patients to whom an AAP was delivered by the physician during the intervention period (52 weeks) compared to the baseline period (52 weeks). [ Time Frame: Every 2 weeks for 6 months ] [ Designated as safety issue: No ]
- The impact of an eAAP system on patient-relevant outcomes including hospitalisations, ER visits, unscheduled & total visits to the doctor, days off work/school, nocturnal & daytime asthma symptoms, daytime rescue bronchodilator use, & quality of life [ Time Frame: Every 2 weeks for 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 500 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Electronic Asthma Action Plan System
Electronic Asthma Action Plan System
|
Other: Electronic Asthma Action Plan System
The electronic asthma action plan system consists of a tablet device in the physician waiting room which participants use to complete a simple questionnaire, a computerized clinical decision support system which then processes these data to produce a set of asthma care recommendations for the clinician, and finally, a printable asthma action plan that is given to patients, along with the URL for an asthma education website.
|
Eligibility| Ages Eligible for Study: | 16 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Eligible physicians will include all primary care physicians at the 2 sites.
Eligible patients will include:
- patients with physician-diagnosed asthma, as listed in their current diagnoses in the physician's chart,
- >/= 16 years of age.
- Patients with no computer and/or internet access at home will be unable to enroll and participate from home or to provide patient-level outcome data, but can still use the portable device in the waiting room and therefore will be considered eligible for the primary outcome.
Exclusion Criteria:
- Patients who received an AAP within the last 6 months (from their primary care physician, a respirologist, or any other source).
- Pregnant patients will be excluded given that conventional AAP recommendations may not be appropriate in this population.
Contacts and Locations| Contact: Samir Gupta | 416-864-6026 | guptas@smh.toronto.on.ca |
| Contact: Sharon Straus | 416-864-6060 ext 5431 |
| Canada, Ontario | |
| McMaster Family Health Team | Recruiting |
| Hamilton, Ontario, Canada, L8N 3Z6 | |
| St. Michael's Hospital | Not yet recruiting |
| Toronto, Ontario, Canada, M5B 1W8 | |
| Contact: Susan Hall halls@smh.ca | |
| Principal Investigator: Samir Gupta | |
More Information
No publications provided
| Responsible Party: | St. Michael's Hospital, Toronto |
| ClinicalTrials.gov Identifier: | NCT01070095 History of Changes |
| Other Study ID Numbers: | 10-0052 |
| Study First Received: | February 16, 2010 |
| Last Updated: | January 14, 2013 |
| Health Authority: | Canada: Ethics Review Committee |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013